Tascit Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

K citrate

Indications/Uses

Management of renal tubular acidosis (RTA) w/ Ca stones; hypocitraturic Ca oxalate nephrolithiasis of any etiology; uric acid lithiasis w/ or w/o Ca stones. Prevention of stone relapse after extracorporeal shock wave lithotripsy (ESWL) or lithotomy.

Click to view Tascit detailed prescribing information

Dosage/Direction for Use

Adult Severe hypocitraturia (urinary citrate <150 mg/day) 60 mEq/day in 2 or 3 divided oral doses (30 mEq bid or 20 mEq tid). Mild to moderate hypocitraturia (urinary citrate >150 mg/day) 30 mEq/day in 2 or 3 divided oral doses (15 mEq bid or 10 mEq tid).

Click to view Tascit detailed prescribing information

Overdosage

View Tascit overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Take 30 min after meals. Swallow whole, do not crush/chew/suck.

Contraindications

Hypersensitivity. Patients w/ hyperkalemia or conditions predisposing to hyperkalemia eg, chronic renal failure, uncontrolled DM, familial hyperkalemic periodic paralysis, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown, severe myocardial damage, administration of K-sparing diuretic (eg, triamterene, spironolactone or amiloride). Slow gastric emptying, esophageal compression, intestinal obstruction or stricture; anticholinergic therapy; active PUD; active UTI; renal insufficiency; resp or metabolic acidosis.

Click to view Tascit detailed prescribing information

Special Precautions

Avoid in patients w/ chronic renal failure or impaired K excretion eg, severe myocardial damage or heart failure. Discontinue if severe vomiting, abdominal pain or GI bleeding occurs & investigate possibility of bowel perforation or obstruction. Monitor serum K regularly. Discontinue if hyperkalemia occurs. Pregnancy & lactation. Childn.

Click to view Tascit detailed prescribing information

Use In Pregnancy & Lactation

Click to view Tascit detailed prescribing information

Adverse Reactions

Minor GI complaints eg, abdominal discomfort, vomiting, diarrhea, loose bowel movement & nausea.

Click to view Tascit detailed prescribing information

Drug Interactions

Severe hyperkalemia w/ K-sparing diuretics (eg, triamterene, spironolactone or amiloride). Increased GI irritation w/ drugs that slow GI transit time (eg, anticholinergics).

Click to view Tascit detailed prescribing information

Storage

View Tascit storage conditions for details to ensure optimal shelf-life.

Description

View Tascit description for details of the chemical structure and excipients (inactive components).

Action

View Tascit mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

A12BA02 - potassium citrate ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.

Regulatory Classification

Presentation/Packing

Form

Tascit XR tab 10 mEq

Packing/Price

100's;30's

Form

Tascit XR tab 15 mEq

Packing/Price

100's

Tascit

potassium citrate

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc